Related Experiment Video
Updated: May 27, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Resident cardiac stem cells
1Department of Internal Medicine and Biomedical Science University Hospital of Parma, 43100 Parma, Italy.
Insights
Stem cells offer new cardiovascular disease treatments. Cardiac stem progenitor cells (CSPCs) show potential for regenerating damaged hearts and treating heart failure.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Biology
Background:
- Stem cell therapy presents novel approaches for cardiovascular disease treatment.
- The heart's self-renewal capacity and the role of myocardial progenitor cells are key to understanding cardiac regeneration.
- Previous studies demonstrated the feasibility of bone marrow cell therapy for ischemic cardiomyopathies.
Purpose of the Study:
- To review the potential role of cardiac stem progenitor cells (CSPCs) in heart failure.
- To explore regenerative strategies for preserving and expanding endogenous CSPCs.
Main Methods:
- Review of current literature on cardiac stem progenitor cells.
- Analysis of methodologies for CSPC isolation and characterization.
- Discussion of experimental and clinical findings in stem cell cardiology.
Main Results:
- Cardiac stem progenitor cells (CSPCs) have been isolated from the human heart, though methodologies vary.
- CSPCs may play a role in the pathogenesis and progression of congestive heart failure.
- Regenerative approaches targeting CSPCs offer potential for heart repair.
Conclusions:
- Cardiac stem progenitor cells (CSPCs) are crucial for understanding heart regeneration and treating cardiovascular diseases.
- Further research is needed to standardize CSPC isolation and application.
- Preserving and expanding the resident pool of CSPCs holds promise for reversing heart failure through regenerative medicine.
Abstract:
The introduction of stem cells in cardiology provides new tools in understanding the regenerative processes of the normal and pathologic heart and opens new options for the treatment of cardiovascular diseases. The feasibility of adult bone marrow autologous and allogenic cell therapy of ischemic cardiomyopathies has been demonstrated in humans. However, many unresolved questions remain to link experimental with clinical observations. The demonstration that the heart is a self-renewing organ and that its cell turnover is regulated by myocardial progenitor cells offers novel pathogenetic mechanisms underlying cardiac diseases and raises the possibility to regenerate the damaged heart. Indeed, cardiac stem progenitor cells (CSPCs) have recently been isolated from the human heart by several laboratories although differences in methodology and phenotypic profile have been described. The present review points to the potential role of CSPCs in the onset and development of congestive heart failure and its reversal by regenerative approaches aimed at the preservation and expansion of the resident pool of progenitors.
Related Concept Videos
Stem Cell Culture
Adult Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Embryonic Stem Cells

